title: Chronic myeloid leukemia following heart transplantation and immunosuppression with tacrolimus.
authors.affiliation: Kimmel Cancer Center, Department of Medical Oncology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA.
authors.forename: Maria M
authors.initials: MM
authors.lastname: Sbenghe
authors.forename: Alin Dulau
authors.initials: AD
authors.lastname: Florea
authors.forename: Paul
authors.initials: P
authors.lastname: Mather
authors.forename: Elena
authors.initials: E
authors.lastname: Gitelson
mesh_terms: D009202:Cardiomyopathies / Q000628:therapy; D016044:Fusion Proteins, bcr-abl / Q000235:genetics; D016027:Heart Transplantation / Q000276:immunology*; D006801:Humans; D016867:Immunocompromised Host / Q000187:drug effects*; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000175:diagnosis* / Q000209:etiology* / Q000276:immunology; D007958:Leukocyte Count; D008297:Male; D008875:Middle Aged; D010677:Philadelphia Chromosome; D010976:Platelet Count; D011183:Postoperative Complications / Q000175:diagnosis* / Q000276:immunology; D016559:Tacrolimus / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D007166:Immunosuppressive Agents; D016044:Fusion Proteins, bcr-abl; D016559:Tacrolimus